首页> 外国专利> METHOD FOR DETERMINING FALSE NEGATIVE AND FALSE POSITIVE REACTIONS FOR TARGET PATHOGEN GENE DETECTION BASED ON INTERNATIONAL STANDARD REAL-TIME RT-PCR OF VIRAL HAEMORRHAGIC SEPTICAEMIA

METHOD FOR DETERMINING FALSE NEGATIVE AND FALSE POSITIVE REACTIONS FOR TARGET PATHOGEN GENE DETECTION BASED ON INTERNATIONAL STANDARD REAL-TIME RT-PCR OF VIRAL HAEMORRHAGIC SEPTICAEMIA

机译:基于国际标准实时RT-PCR的毒性出血性遗产症的靶病原体基因检测确定假阴性和假阳性反应的方法

摘要

The present invention relates to a method for discriminating false negatives and false positives that may appear in the detection of a pathogen gene of a target disease based on a real-time RT-PCR method for viral hemorrhagic sepsis, and more specifically, (1) Jonstrup VHS rRT-PCR Synthesizing by linking and synthesizing a nucleotide sequence according to the law and a gene for a nucleotide sequence for detecting a pathogen gene of a target disease and determining false positives; (2) Dilute the synthesized gene stepwise and use each dilution as a template, but perform the Jonstrup VHS rRT-PCR method and the rRT-PCR reaction for detecting the pathogen gene of the target disease, respectively, and compare the detection sensitivity for the two reactions. Selecting a synthetic nucleotide sequence for detection of a disease pathogen gene; (3) extracting synthetic recombinant plasmid DNA by cloning the gene synthesized in step (1) into a plasmid DNA vector; (4) Using the extracted synthetic recombinant plasmid DNA as a template, primers and probes according to the synthetic nucleotide sequence for detection of the pathogen gene of the target disease selected in step (2), for VHSV detection according to the Jonstrup VHS rRT-PCR method Incorporating primers and probes, primers and probes for detection of plasmid vector DNA into a real-time PCR cocktail preparation, and performing multiple real-time RT-PCR; (5) From the results of the multiple real-time RT-PCR, by comparing the detection sensitivity of VHSV and the detection sensitivity of the pathogen gene of the target disease, verifying the sensitivity of the pathogen gene detection method of the target disease, false by using the low sensitivity detection method. Preventing negative reactions; (6) using the synthetic recombinant plasmid DNA as a positive control, when diagnosing the target disease, confirming the success of multiple real-time PCR experiments for detection of the target disease pathogen gene without direct use of the target disease pathogen; (7) When diagnosing the target disease, if the pathogen of the target disease is an RNA virus, the real-time to determine the success of RNA extraction and cDNA synthesis by setting the eukaryotic common gene detection as an internal control. Incorporating a eukaryotic common gene detection primer and a probe into the PCR cocktail preparation, verifying the RNA extraction and cDNA synthesis experimental process through confirmation of the internal control fluorescence reaction; And (8) at the time of diagnosis of the target disease, determining false negatives and false positives by confirming multiple fluorescence reaction results. According to the method for determining false negatives and false positives that may appear in the detection of the pathogen gene of the target disease based on the real-time RT-PCR method for viral hemorrhagic sepsis proposed in the present invention, Jonstrup standardized on a structurally stable plasmid DNA vector. Synthetic recombinant plasmid DNA is extracted by cloning a synthetic gene containing the base sequence according to the VHS rRT-PCR method and the base sequence for detecting the target disease at the same time, and comparing the detection sensitivity of real-time RT-PCR performed using this, the target disease By verifying the effectiveness of the detection sensitivity of the pathogen gene and adjusting it, it is possible to establish a method for detecting a high-sensitivity gene for the target disease within a short period of time. In addition, according to the method for determining false negatives and false positives that may appear in the detection of the pathogen gene of the target disease based on the real-time RT-PCR method for viral hemorrhagic sepsis proposed in the present invention, whether the plasmid vector gene is detected and amplified By comparing the levels, it is possible to determine whether or not the synthetic recombinant plasmid DNA used as a positive control is contaminated. In addition, according to the method for determining false negatives and false positives that may appear in the detection of the pathogen gene of the target disease based on the real-time RT-PCR method for viral hemorrhagic sepsis proposed in the present invention, the detection of the 18s rRNA gene is determined. In comparison, it is possible to discriminate against contamination that may occur due to mold in the laboratory or carelessness of the experimenter, and comprehensively control false positive and false negative responses to the diagnostic sample of the target disease.
机译:本发明涉及一种用于区分假否定和假阳性的方法,其基于用于病毒出血败血症的实时RT-PCR方法,可以出现在检测目标疾病的病原体基因中,更具体地,(1) Jonstrup VHS RRT-PCR通过将核苷酸序列和基因连接和合成核苷酸序列来合成核苷酸序列,用于检测靶疾病的病原体基因并确定假阳性; (2)逐步稀释合成基因,并使用每个稀释作为模板,但是进行Jonstrup VHS RRT-PCR方法和用于检测目标疾病的病原体基因的RRT-PCR反应,并比较检测灵敏度两个反应。选择用于检测疾病病原体基因的合成核苷酸序列; (3)通过将步骤(1)中合成的基因克隆到质粒DNA载体中,提取合成的重组质粒DNA; (4)根据合成核苷酸序列,使用提取的合成重组质粒DNA作为模板,引物和探针,用于检测在步骤(2)中选择的靶疾病的病原体基因,根据JONSTRUP VHS RRT-进行VHSV检测PCR方法掺入引物和探针,引物和探针,用于检测质粒载体DNA分为实时PCR鸡尾酒制剂,并进行多种实时RT-PCR; (5)通过多种实时RT-PCR的结果,通过比较VHSV的检测灵敏度和目标疾病病原体基因的检测灵敏度,验证靶疾病病原体基因检测方法的敏感性,使用低灵敏度检测方法假。防止消极反应; (6)使用合成重组质粒DNA作为阳性对照,当诊断靶疾病时,确认多次实时PCR实验的成功,用于检测靶疾病病原体基因而不直接使用靶疾病病原体; (7)在诊断目标疾病时,如果目标疾病的病原体是RNA病毒,则通过将真核常见基因检测作为内部对照确定RNA提取和cDNA合成的实时。将真核常见基因检测引物和探针掺入PCR鸡尾酒制剂中,通过确认内部对照荧光反应来验证RNA提取和cDNA合成实验过程; (8)在诊断目标疾病时,通过证实多种荧光反应结果来确定假阴性和误报。根据本发明中提出的病毒出血败血症的实时RT-PCR方法在检测到目标疾病的病原体基因中,根据本发明提出的实时RT-PCR方法,根据本发明的实时RT-PCR方法,根据本发明的实际RT-PCR方法,根据结构疾病的测定方法,在结构上标准化稳定的质粒DNA载体。通过克隆根据VHS RRT-PCR方法和碱基序列同时克隆含有碱基序列的合成基因来提取合成重组质粒DNA,并比较实时RT-PCR的检测灵敏度进行碱基序列使用这一点,通过验证病原体基因的检测灵敏度的有效性并调节它来确定靶疾病,可以建立在短时间内检测靶疾病的高敏感性基因的方法。另外,根据用于在本发明中提出的实时RT-PCR方法检测目标疾病的病原体基因的假否定和误报的方法,是否通过比较水平检测和扩增质粒载体基因,可以确定用作阳性对照的合成重组质粒DNA是否被污染。另外,根据用于确定本发明中提出的实时RT-PCR方法,根据本发明中提出的病毒出血败血症的实时RT-PCR方法检测到靶疾病的病原体基因的假否定和假阳性的方法。检测确定了18s的RRNA基因。相比之下,可以歧视可能在实验室的实验室或粗心的模具中发生的污染,并全面控制对目标疾病的诊断样本的假阳性和假阴性反应。

著录项

  • 公开/公告号KR102242634B1

    专利类型

  • 公开/公告日2021-04-22

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020200105670

  • 发明设计人 김형준;김영철;김신후;김민지;

    申请日2020-08-21

  • 分类号C12Q1/70;C12Q1/6806;C12Q1/6876;

  • 国家 KR

  • 入库时间 2022-08-24 18:27:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号